Cedars-Sinai Medical Center
Shlomo Melmed, MD
The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.
Pituitary Tumor
The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity through computerized collection of comprehensive demographic, therapeutic, pathologic and outcome information on patients harboring pituitary mass lesions of all types.
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 1250 participants |
| Official Title : | Pituitary Tumor Surveillance: Pathogenetic Correlation |
| Actual Study Start Date : | 1997-01 |
| Estimated Primary Completion Date : | 2050-12 |
| Estimated Study Completion Date : | 2050-12 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Cedars-Sinai Medical Center, Pituitary Center
Los Angeles, California, United States, 90048